These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26427454)

  • 81. Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.
    Errington SJ; Mann CJ; Fletcher S; Wilton SD
    J Gene Med; 2003 Jun; 5(6):518-27. PubMed ID: 12797117
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Advances in therapeutic RNA-targeting.
    van Ommen GJ; Aartsma-Rus A
    N Biotechnol; 2013 Mar; 30(3):299-301. PubMed ID: 23369867
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Antisense Oligonucleotide (AON)-based Therapy for Leber Congenital Amaurosis Caused by a Frequent Mutation in CEP290.
    Collin RW; den Hollander AI; van der Velde-Visser SD; Bennicelli J; Bennett J; Cremers FP
    Mol Ther Nucleic Acids; 2012 Mar; 1(3):e14. PubMed ID: 23343883
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Antisense oligonucleotides as modulators of pre-mRNA splicing.
    Sierakowska H; Agrawal S; Kole R
    Methods Mol Biol; 2000; 133():223-33. PubMed ID: 10561842
    [No Abstract]   [Full Text] [Related]  

  • 85. A Cost-Effective Mutation Screening Strategy for Inherited Retinal Dystrophies.
    Barandika O; Irigoyen C; Anasagasti A; Egiguren G; Ezquerra-Inchausti M; López de Munain A; Ruiz-Ederra J
    Ophthalmic Res; 2016; 56(3):123-31. PubMed ID: 27160245
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Gene therapy for hereditary eye diseases].
    Kessel L; Bertelsen M; Klemp K; Christensen UC
    Ugeskr Laeger; 2022 Nov; 184(45):. PubMed ID: 36345897
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Inherited Retinal Dystrophies: the role of gene expression regulators.
    Karali M; Banfi S
    Int J Biochem Cell Biol; 2015 Apr; 61():115-9. PubMed ID: 25697419
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Retinal Inflammation, Cell Death and Inherited Retinal Dystrophies.
    Olivares-González L; Velasco S; Campillo I; Rodrigo R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672611
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Gene therapy for retinal dystrophy.
    Sahel JA; Dalkara D
    Nat Med; 2019 Feb; 25(2):198-199. PubMed ID: 30718907
    [No Abstract]   [Full Text] [Related]  

  • 90. Gene-Based Therapeutics for Inherited Retinal Diseases.
    Fenner BJ; Tan TE; Barathi AV; Tun SBB; Yeo SW; Tsai ASH; Lee SY; Cheung CMG; Chan CM; Mehta JS; Teo KYC
    Front Genet; 2021; 12():794805. PubMed ID: 35069693
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Emerging Drug Therapies for Inherited Retinal Dystrophies.
    Sundaramurthi H; Moran A; Perpetuini AC; Reynolds A; Kennedy B
    Adv Exp Med Biol; 2019; 1185():263-267. PubMed ID: 31884622
    [TBL] [Abstract][Full Text] [Related]  

  • 92. CRISPR/Cas9 corrects retinal dystrophy in rats.
    Graham DM
    Lab Anim (NY); 2016 Mar; 45(3):85. PubMed ID: 26886660
    [No Abstract]   [Full Text] [Related]  

  • 93. Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations.
    Talib M; Boon CJF
    Asia Pac J Ophthalmol (Phila); 2020; 9(3):159-179. PubMed ID: 32511120
    [TBL] [Abstract][Full Text] [Related]  

  • 94. RNA Therapeutics: How Far Have We Gone?
    Coutinho MF; Matos L; Santos JI; Alves S
    Adv Exp Med Biol; 2019; 1157():133-177. PubMed ID: 31342441
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Delivery of Antisense Oligonucleotides to the Mouse Retina.
    Garanto A
    Methods Mol Biol; 2022; 2434():321-332. PubMed ID: 35213028
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Identifying variation in models of care for the genomic-based diagnosis of inherited retinal dystrophies in the United Kingdom.
    Eden M; Payne K; Jones C; Wright SJ; Hall G; McAllister M; Black G
    Eye (Lond); 2016 Jul; 30(7):966-71. PubMed ID: 27080487
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clinical Trials in Retinal Dystrophies.
    Grob SR; Finn A; Papakostas TD; Eliott D
    Middle East Afr J Ophthalmol; 2016; 23(1):49-59. PubMed ID: 26957839
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The potential of antisense oligonucleotide therapies for inherited childhood lung diseases.
    Martinovich KM; Shaw NC; Kicic A; Schultz A; Fletcher S; Wilton SD; Stick SM
    Mol Cell Pediatr; 2018 Feb; 5(1):3. PubMed ID: 29411170
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Therapeutic concepts for inherited retinal dystrophy].
    Charbel Issa P
    Ophthalmologe; 2012 Feb; 109(2):110-1. PubMed ID: 22350546
    [No Abstract]   [Full Text] [Related]  

  • 100. Genetic testing and diagnosis of inherited retinal diseases.
    Lam BL; Leroy BP; Black G; Ong T; Yoon D; Trzupek K
    Orphanet J Rare Dis; 2021 Dec; 16(1):514. PubMed ID: 34906171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.